"Ablate and pace"可降低心力衰竭患者心房的死亡率:一个更新的元分析
Christian Lewinter1,2,3, John G F Cleland2, Eslem Sögütlü3
1Heart Centre, Karolinska University Hospital, Eugeniavägen 3, SE-171 76 Stockholm, Sweden.
European heart journal open
|March 16, 2026
概括
与药物治疗相比,Ablate和步伐疗法显著降低了心力衰竭患者与心房的死亡率. 在两组治疗中,左心室喷射分数的结果在两组治疗中是相似的.
科学领域:
- 心脏病学 心脏病学
- 电力生理学 电力生理学
- 心脏衰竭管理的管理
背景情况:
- 心房动 (AF) 是一种常见的心律失常,通常通过药理疗法进行治疗.
- 心力衰竭 (HF) 复杂化了AF管理,影响了患者的治疗结果.
- "绝对和节奏"策略,特别是心脏再同步疗法 (CRT),是替代治疗选择.
研究的目的:
- 为了比较"ablate and pace"与药物治疗在AF患者中的疗效,根据HF的存在或不存在分层.
- 评估这些策略对所有原因死亡率和左心室喷射率 (LVEF) 的影响.
主要方法:
- 在PubMed,Central和Embase数据库中进行了系统的文献搜索,截至2024年6月.
- 对24项观察性和随机对照试验 (RCT) 的数据进行了元分析,涉及4292名患者.
- 主要结局包括全因死亡率和LVEF的平均差异,并对患有和没有HF的患者进行亚组分析.
主要成果:
- 与药物治疗相比",Ablate and pace"显著降低了HF患者的死亡率36% (RR,0.64;95% CI,0.49-0.85).
- 这种死亡益处在RCT和观察性研究中是一致的.
- 在"ablate和步伐"和药物治疗之间没有观察到LVEF的显著差异 (MD,1.1;95% CI,-1.6-3.8).
结论:
- "绝对和步伐",主要使用CRT,为AF患者提供了显著的生存优势与同时存在的HF相比以药物为基础的管理.
- 与药物治疗相比,该策略对LVEF改善没有显著的影响.
- 观察性研究的证据强烈支持这种死亡益处,单个RCT证实了这些发现.
相关概念视频
Dysrhythmias VI: Management of Dysrhythmias
577
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
577
Disturbances in Heart Rhythm
3.5K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
3.5K
Heart Failure V: Medical Management
470
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
470
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
814
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
814
Cardiopulmonary Resuscitation III: AED Use
1.1K
Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
1.1K
Heart Failure VI: Adjunct Therapies
506
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
506


